Ultime notizie per Nextracker (NASDAQ:NXT) Azioni

NEXTRACKER INC-CL A

NEXTracker

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Jim Cramer

News

Media

COST

CRWD

L&#39;analista di Mad Money giudica titoli tech, aerei e retail. Cautela sul settore viaggi, ma elogi per un nome della cybersecurity.

Cramer suona l&#39;allarme su Alaska Air, ma quest&#39;altro titolo è &#34;Eccezionale&#34;

Nextracker Inc

NEXT BIOMETRICS GRP ORD by Next Biometrics Group AS

Next Biometrics Group ASA

NextCure Inc

NEXTGEN DIGITAL PLATFORMS by NextGen Digital Platforms Inc.

Nextgen Digital Platforms Inc

Investment Managers Series Trust II AXS Green Alpha ETF

NEXTRACTION ENERGY CORP by Nextraction Energy Corp.

Nextraction Energy Corp

First Trust Indxx NextG ETF

NXT NUTRITIONALS HLDG INC by NXT Nutritionals Holdings, Inc.

NXT Nutritionals Holdings Inc

Simplify Exchange Traded Funds Simplify Next Intangible Core Index ETF

Next10 Inc

NEXSTIM OYJ by NEXSTIM OYJ

NEXTPLAY TECHS INC by NextPlay Technologies, Inc.

NextPlay Technologies Inc

Next Technology Holding Inc. - Ordinary Shares

Next Technology Holding Inc

Lifeist Wellness Inc

Simplify Exchange Traded Funds Simplify Next Intangible Value Index ETF

NEXITY FINANCIAL CORP by Nexity Financial Corp.

Nexity Financial Corp

OSR Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>), a public company dedicated to advancing innovation in healthcare and wellness, announced today that it has entered into a Memorandum of Understanding (MOU) with BCM Europe AG, its major shareholder, and Taekwondo Cooperative (TKD Coop), a global Taekwondo community organization, to explore the joint development of a security token, provisionally named the "OSRH Token". The initiative aims to enhance access to crypto-based liquidity and&nbsp;provide a basis for OSRH to launch crypto treasury strategies.

OSRH

OSR Holdings Enters Into MOU With BCM Europe And Taekwondo To Explore Joint Development Of Security Token, Provisionally Named "OSRH Token"

Barclays analyst David Strauss initiates coverage on Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with a Equal-Weight rating and announces Price Target of $13.

Price Target

Initiation

Analyst Ratings

LUNR

Barclays Initiates Coverage On Intuitive Machines with Equal-Weight Rating, Announces Price Target of $13

Needham analyst Gerald Pascarelli initiates coverage on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy rating and announces Price Target of $195.

Needham Initiates Coverage On Philip Morris Intl with Buy Rating, Announces Price Target of $195

GBIO

GIBO Introduces AIARSE: AI-Powered Asset Recognition Engine To Monetize Creator Contributions And Enforce IP Rights

Digi Power X Inc. ("Digi Power X" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGXX#NASDAQ">DGXX</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DGX#TSXV">DGX</a>), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is pleased to announce that US Data Centers, Inc., a wholly owned subsidiary of the Company, has entered into a collaboration with Super Micro Computer, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) to deploy customized B200 GPU rack solutions at the Company's newly developed data center in Alabama.
The collaboration will begin with an initial deployment targeting operational readiness within 120 days, with full test operations expected during Q4 2025. This project lays the foundation for a broader expansion at the Alabama site, with plans to scale up to 22 megawatts (MW) in 2026 and 55MW by 2027.

DGXX

SMCI

TSXV:DGX

Digi Power X's US Data Centers Collaborates With Super Micro Computer To Deploy Customized B200 GPU Rack Solutions At Newly Developed Data Center In Alabama

Contracts

Redwire Lands Avionics Contract For ESA's NGGM, Supporting MAGIC's Mission To Monitor Sea Level Rise And Ice Melt

Needham analyst Gerald Pascarelli initiates coverage on Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Hold rating.

Needham Initiates Coverage On Altria Group with Hold Rating

SLNH

Soluna Signs Term Sheet For 75 MW Data Center

Barclays analyst Lydia Rainforth downgrades Equinor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) from Overweight to Equal-Weight.

Downgrades

EQNR

Barclays Downgrades Equinor to Equal-Weight

QNRX

Quoin Pharmaceuticals Receives FDA Clearance To Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) on Thursday disclosed that it will acquire Johnson Matthey&#8216;s Catalyst Technologies division in an all-cash deal valued <a href="https://www.benzinga.com/pressreleases/25/05/n45557790/honeywell-to-acquire-johnson-mattheys-catalyst-technologies-business-expanding-portfolio-of-leadin" target="_blank" rel="noreferrer noopener">at 1.8 billion pounds ($2.4 billion)</a>.
The purchase price represents roughly 11 times the projected 2025 EBITDA, factoring in tax advantages and anticipated cost synergies.
By integrating Catalyst Technologies with Honeywell&#8217;s Energy and Sustainability Solutions (ESS) segment, the company expects to enhance its portfolio with promising high-growth opportunities and realize substantial additional cost efficiencies.
Also Read: <a href="https://www.benzinga.com/25/03/44109915/honeywell-acquires-sundyne-for-216-billion-expanding-energy-and-industrial-equipment-portfolio" target="_blank" rel="noreferrer noopener">Honeywell Acquires Sundyne For $2.16 Billion, Expands Energy And Industrial Equipment Portfolio</a>
The company said that Johnson Matthey&#8217;s Catalyst Technologies business aligns well with Honeywell&#8217;s existing UOP operations, which focus on catalysts and process technologies and will broaden Honeywell&#8217;s footprint in the refining and petrochemical catalyst markets.
This acquisition also enables Honeywell, for the first time, to deliver an end-to-end solution for producing lower-emission, essential fuels such as sustainable methanol, sustainable aviation fuel (SAF), blue hydrogen, and blue ammonia, contributing to both energy security and emissions reduction.
The expanded offerings will include licensed technologies, engineering expertise, support services, and catalysts for transforming hydrocarbon and renewable feedstocks into high-value products.
The transaction is expected to be completed by the first half of 2026, pending standard closing conditions and regulatory approvals.
The acquisition is anticipated to contribute positively to earnings within the first year and is expected to introduce high-growth opportunities to Honeywell&#8217;s Energy and <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">Sustainability Solutions (ESS) division</a>.
This move follows Honeywell&#8217;s recently announced plans to spin off its Aerospace Technologies <a target="_blank" href="https://www.benzinga.com/news/asset-sales/24/12/42505835/honeywell-advances-strategic-review-explores-aerospace-business-separation" rel="noreferrer noopener">and Advanced Materials businesses</a>.
These separations will result in three independent, publicly traded companies with a focused strategy and distinct growth drivers.
Also, the company remains on track to surpass its goal of allocating at least $25 billion through 2025 across high-return investments, dividend payments, selective share <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">repurchases, and strategic acquisitions</a>.
In April, the company&nbsp;reported&nbsp;first-quarter revenue&nbsp;of&nbsp;$9.82 billion, beating the consensus of&nbsp;$9.59 billion, and adjusted EPS was&nbsp;$2.51 (+7% Y/Y),&nbsp;<a target="_blank" href="https://www.benzinga.com/25/04/45066884/honeywell-q1-strong-growth-in-aerospace-offsets-industrial-dip-narrows-outlook-amid-uncertain-demand-scenario" rel="noreferrer noopener">beating the consensus of&nbsp;$2.21</a>.
Honeywell held cash and equivalents of about&nbsp;$9.66 billion as of March 31, 2025.
Investors can gain exposure to the stock via Themes Transatlantic Defense ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATO#NASDAQ">NATO</a>) and Gabelli Commercial Aerospace and Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCAD#NYSE">GCAD</a>).
Price Action: HON shares are trading higher by 0.13% to $222.17 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/25/04/45109933/honeywell-international-posts-q1-beat-heres-what-could-affect-performance-in-h2-analyst-raises-price-target" target="_blank" rel="noreferrer noopener">Honeywell International Posts Q1 Beat: Here&#8217;s What Could Affect Performance In H2, Analyst Raises Price Target</a></li>
</ul>
Image via Shutterstock

Equities

Large Cap

GCAD

NATO

Honeywell Deepens Renewable Fuels Push With $2.4 Billion Deal

JP Morgan analyst Ryan Brinkman reinstates Goodyear Tire &amp; Rubber (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) with a Overweight and lowers the price target from $18 to $17.

JP Morgan Reinstates Overweight on Goodyear Tire & Rubber, Lowers Price Target to $17

HC Wainwright &amp; Co. analyst Emily Bodnar assumes RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) with a Buy rating and announces Price Target of $6.

RAPT

HC Wainwright & Co. Assumes RAPT Therapeutics at Buy, Announces Price Target of $6

Needham analyst Mayank Tandon maintains Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) with a Buy and raises the price target from $28 to $33.

NCNO

Needham Maintains Buy on Ncino, Raises Price Target to $33

Vigil Neuroscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) on Wednesday disclosed that it entered a deal to be acquired by Sanofi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) for&nbsp;an equity value of approximately <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45555759/vigil-neuroscience-enters-into-definitive-merger-agreement-to-be-acquired-by-sanofi" rel="noreferrer noopener">$470 million (on a fully diluted basis)</a>.
Per the terms, Sanofi will pay $8.00 per share in cash to acquire Vigil. In addition, shareholders will be granted a non-tradeable contingent value right (CVR), which could provide an extra $2.00 per share in cash if VG-3927 achieves its first commercial sale <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45555705/press-release-sanofi-to-acquire-vigil-neuroscience-inc-adding-a-new-investigational-medicine-to-tr" rel="noreferrer noopener">within a designated timeframe</a>.
The total equity value of the transaction, including the potential CVR payment, represents approximately $600 million on a fully diluted basis.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43167375/vigil-neurosciences-alzheimers-candidate-shows-encouraging-safety-profile-plans-to-start-mid-stage-study-in-q3" rel="noreferrer noopener">Vigil Neuroscience&#8217;s Alzheimer&#8217;s Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3</a>
This acquisition, expected to close in the third quarter of 2025, strengthens Sanofi&#8217;s neurology pipeline with VG-3927, an oral TREM2 agonist for Alzheimer&#8217;s disease, addressing a critical unmet need in treatment.
Ivana Magovčević-Liebisch, Ph.D., J.D., President and CEO of Vigil, said, &#8220;Sanofi&#8217;s development capabilities, therapeutic expertise, global footprint, and financial strength provide the greatest opportunity to further the development of VG-3927 for the potential treatment of Alzheimer&#8217;s disease and potentially bring this important and differentiated therapy to those struggling with the immense burden of this disease.&#8221;
Houman Ashrafian, M.D., Ph.D., Head of Research and Development of Sanofi, added, &#8220;TREM2 represents a compelling target at the intersection of immune dysregulation and neurodegeneration, particularly in people living with Alzheimer&#8217;s because they face devastating cognitive decline with limited treatment options.&#8221;
In April 2025, Vigil Neuroscience presented new data from its oral small molecule program, featuring its lead candidate, VG-3927, through two oral presentations at the AD/PD 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44603290/vigil-neuroscience-presents-data-on-its-small-molecule-trem2-agonist-vg-3927-in-two-oral-presentat" rel="noreferrer noopener">International Conference in Austria</a>.
At that time, Ivana Magovčević-Liebisch said the two presentations highlight the strong potential of VG-3927. This oral, brain-penetrant TREM2 agonist showed positive results in Phase 1, with good safety, tolerability, and drug activity.
She further explained that VG-3927 could offer a new way to treat Alzheimer&#8217;s disease by targeting more than just amyloid buildup.
Vigil plans to begin Phase 2 trials of VG-3927, the only once-daily oral TREM2 agonist currently in clinical development, later this year.
Vigil&#8217;s monoclonal antibody program, Iluzanebart (VGL101), is excluded from the acquisition by Sanofi. Before the transaction is finalized, the exclusive license agreement with Amgen for VGL101 will be terminated, and the rights to the program will be returned to Amgen, its original licensor.
Price Action: SNY shares were trading lower by 0.36% to $52.71 premarket at last check Thursday, and VIGL shares traded higher by 245.9% at $7.99.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45419235/sanofi-joins-other-big-pharma-to-navigate-potential-tariff-impact-with-at-least-20-billion-in-investments-through-2030" target="_blank" rel="noreferrer noopener">Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030</a></li>
</ul>
Image by HJBC via Shutterstock

Biotech

Health Care

Movers

VIGL

Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

HC Wainwright &amp; Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) with a Buy and lowers the price target from $110 to $105.

HC Wainwright & Co. Maintains Buy on Instil Bio, Lowers Price Target to $105

JP Morgan analyst Matthew Boss upgrades Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) from Neutral to Overweight and raises the price target from $63 to $78.

Upgrades

URBN

JP Morgan Upgrades Urban Outfitters to Overweight, Raises Price Target to $78

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Neutral and maintains $40 price target.

Reiteration

SRPT

HC Wainwright & Co. Reiterates Neutral on Sarepta Therapeutics, Maintains $40 Price Target

The Chairman and CEO of JPMorgan Chase &amp; Co., Jamie Dimon, addressed the issues surrounding huge deficits, inflationary factors, and geopolitical risk in the U.S. economy while talking <a href="https://www.bloomberg.com/news/articles/2025-05-22/jpmorgan-s-dimon-sees-risk-of-stagflation-for-us-economy?srnd=homepage-asia">to</a> Bloomberg Television at the Global China Summit in Shanghai.
What Happened: While Dimon agreed with the Federal Reserve to wait and see before they decide to cut interest rates, he said that the U.S. economy was likely to fall into &#8220;stagflation&#8221; as the country faces huge risks from geopolitics, deficits, and price pressures.
"I don't agree that we're in a sweet spot," he told Bloomberg Television.
Stagflation describes an economic scenario where there is slow economic growth combined with high inflation.
Addressing the first round of trade talks with China, which resulted in the 90-day tariff truce, Dimon highlighted that "I don't think the American government wants to leave China.&#8221;
"I hope they have a second round, third round, or fourth round, and hopefully it will end up in a good place."
Furthermore, Dimon highlighted during the interview that the U.S. needed to "attack the deficit problems," while justifying how this would affect investors to reduce their positions in the U.S. dollar assets.
"I don't worry about short-term fluctuations in the dollar," Dimon said. "But I do understand people might be reducing dollar assets."
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45541408/cathie-woods-ark-invest-says-nuclear-energy-could-overtake-solar-as-cheapest-power-source-heres-a-list-of-nuclear-energy-linked-etfs-to-consider">Cathie Wood&#8217;s Ark Invest Says Nuclear Energy Could Overtake Solar As Cheapest Power Source: Here&#8217;s A List Of Nuclear Energy Linked ETFs To Consider</a>
Why It Matters: While Donald Trump&#8216;s &#8220;One Big Beautiful Bill&#8221; is likely to raise the trade deficit as per the<a href="https://www.benzinga.com/markets/equities/25/05/45536595/big-beautiful-bill-will-explode-the-deficit-and-make-the-rich-richer-congressional-budget-office-estimates-4-income-fall-for-lowest-decile-of-americans-by-2033"> Congressional Budget Office estimates</a>, the rising long-term Treasury yields stoked by Moody&#8217;s downgraded and Japanese bond yields are also signalling &#8220;debt crisis,&#8221; said Ed Yardeni. 
Meanwhile, the U.S. Dollar Index has declined 7.97% on a year-to-date basis amid the intensifying bond sell-off, which is pushing the yields higher. The 30-year Treasuries surpassed the 5% mark on Wednesday.
This rise in yields pushed the stock markets lower as major benchmark indices closed over 1% lower on Wednesday.
The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 94.7% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting. A 71.2% probability of the same in July and a 67.5% chance of a cut in the September meeting. 
On Thursday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket. The SPY was up 0.19% to $583.95, while the QQQ advanced 0.26% to $514.39, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45559366/urban-outfitters-navigates-tariff-headwinds-with-diversification-strategies-no-country-accounts-for-more-than-25-of-production">Urban Outfitters Navigates Tariff Headwinds With Diversification Strategies: No Country &#8216;Accounts For More Than 25%&#8217; Of Production </a></li>
</ul>
Photo courtesy: lev radin / Shutterstock

Analyst Color

Government

Macro Economic Events

Macro Notification

Market Summary

Regulations

Bonds

Broad U.S. Equity ETFs

Futures

Forex

Economics

Federal Reserve

Markets

ETFs

General

Jamie Dimon Says US Is Not In A 'Sweet Spot,' Flags Stagflation Risk And Deficit Problems Amid Trump-China Tensions

Jefferies analyst Antonio Pedro Cardoso initiates coverage on Vtex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) with a Hold rating and announces Price Target of $7.3.

VTEX

Jefferies Initiates Coverage On Vtex with Hold Rating, Announces Price Target of $7.3

Press Releases

NXT Investors Have Opportunity to Lead Nextracker Inc. Securities Fraud Lawsuit with the Schall Law Firm

Legal

Nextracker Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 25, 2025 Deadline to file Lead Plaintiff Motion

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Nextracker, Inc. (NASDAQ: NXT); Driven Brands Holdings, Inc. (NASDAQ: DRVN); Extreme Networks, Inc. (NASDAQ: EXTR); and MGP Ingredients, Inc. (NASDAQ: MGPI)

FINAL SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nextracker

NEXTRACKER ALERT: Bragar Eagel & Squire, P.C. is Investigating Nextracker Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Attention Long-Term Shareholders of Dominos Pizza Corp. (NASDAQ: DPZ); Driven Brands Holdings, Inc. (NASDAQ: DRVN); Extreme Networks, Inc. (NASDAQ: EXTR); and Nextracker, Inc. (NASDAQ: NXT): Grabar Law is Investigating Claims on Your Behalf

Comments

Nextracker

Notizie

Ultime notizie per Nextracker (NASDAQ:NXT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO